
Milorgen 75mg/ml Injection
Marketer
RSM Kilitch Pharma Pvt Ltd
Salt Composition
Fosphenytoin (75mg/ml)
Overview Milorgen 75mg/ml Injection
Epileptic seizures are treated with the injectable formulation, Milorgen 75mg/ml. This medication regulates seizure activity by reducing excessive, irregular neuronal firing in the brain. Administration of Milorgen 75mg/ml Injection must be overseen by a medical professional; self-injection is strictly prohibited. Consistent dosing is crucial; complete the prescribed regimen, regardless of symptom improvement. Premature discontinuation, without physician consultation, risks life-threatening, continuous seizures. Caution is advised for those using hormonal contraceptives, as Milorgen 75mg/ml Injection may compromise their effectiveness. Potential adverse effects include nausea, pruritus, impaired motor control, and involuntary eye movements (nystagmus). Drowsiness and vertigo are also possible, necessitating avoidance of activities requiring alertness, such as driving. Local injection site reactions, such as erythema or edema, may occur. While most side effects are transient, persistent or bothersome symptoms warrant immediate medical attention. Strategies to mitigate or prevent side effects may be available.
Primary Ingredients of Milorgen 75mg/ml Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Milorgen 75mg/ml Injection
Convulsive disorders
Major Benefits of Milorgen 75mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Milorgen 75mg/ml Injection:
- Vomiting
- Sleepiness
- Dizziness
- Itching
- Impaired coordination
- Nystagmus (involuntary eye movement)
- Injection site reactions (pain, swelling, redness)
How to use Milorgen 75mg/ml Injection:
Administering this medication will be handled by your physician or their qualified nurse. Self-medication is strictly prohibited.
How Milorgen 75mg/ml Injection works:
Epileptic seizures are managed by the anticonvulsant Milorgen 75mg/ml Injection. Its mechanism of action involves reducing hyperactivity within the brain's neuronal network.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Milorgen 75mg/ml Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Milorgen 75mg/ml Injection during pregnancy poses a confirmed risk to the fetus. Its use should be considered only in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known hazards, as determined by a physician. Always seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Milorgen 75mg/ml Injection poses minimal breastfeeding risk. Research in humans indicates negligible transfer to breast milk, posing no apparent infant harm. Physician consultation is advised.
DrivingUNSAFE
The administration of Milorgen 75mg/ml Injection can potentially reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administering Milorgen 75mg/ml Injection requires careful consideration. Dosage modification of Milorgen 75mg/ml Injection might be necessary. Physician consultation is advised. Kidney disease should be disclosed to your doctor.
LiverCAUTION
For individuals with hepatic impairment, administration of Milorgen 75mg/ml Injection requires careful monitoring. Dosage modification of Milorgen 75mg/ml Injection may be necessary. Physician consultation is advised.
What if you forget to take Milorgen 75mg/ml Injection :
Should you forget a dose of Milorgen 75mg/ml Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Milorgen 75mg/ml Injection
| Label | Value |
|---|---|
| Chemical Type | Hydantoin-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Action Class | Sodium channel-blocking antiepileptic drugs |
